These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11038000)

  • 21. Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease.
    Graeber GM; Gupta NC; Murray GF
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):719-27. PubMed ID: 10096967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorine-18-FDG PET in Paget's disease of bone.
    Cook GJ; Maisey MN; Fogelman I
    J Nucl Med; 1997 Sep; 38(9):1495-7. PubMed ID: 9293817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
    Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence.
    Metser U; Miller E; Lerman H; Even-Sapir E
    AJR Am J Roentgenol; 2007 Nov; 189(5):1203-10. PubMed ID: 17954662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
    Inoue T; Kim EE; Wong FC; Yang DJ; Bassa P; Wong WH; Korkmaz M; Tansey W; Hicks K; Podoloff DA
    J Nucl Med; 1996 Sep; 37(9):1472-6. PubMed ID: 8790196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive grading of musculoskeletal tumors using PET.
    Adler LP; Blair HF; Makley JT; Williams RP; Joyce MJ; Leisure G; al-Kaisi N; Miraldi F
    J Nucl Med; 1991 Aug; 32(8):1508-12. PubMed ID: 1869970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.
    Iagaru A; Quon A; McDougall IR; Gambhir SS
    Clin Nucl Med; 2006 Dec; 31(12):754-60. PubMed ID: 17117068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contribution of FDG-PET in the management of pediatric sarcomas in 2011].
    Kolesnikov-Gauthier H; Leblond P; Rocourt N; Carpentier P
    Bull Cancer; 2011 May; 98(5):501-14. PubMed ID: 21646076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors.
    Uematsu H; Sadato N; Ohtsubo T; Tsuchida T; Nakamura S; Sugimoto K; Waki A; Takahashi N; Yonekura Y; Tsuda G; Saito H; Hayashi N; Yamamoto K; Ishii Y
    J Nucl Med; 1998 Mar; 39(3):453-9. PubMed ID: 9529291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer].
    Demura Y; Mizuno S; Wakabayashi M; Totani Y; Okamura S; Ameshima S; Ishizaki T; Miyamori I; Ito H; Yonekura Y
    Nihon Kokyuki Gakkai Zasshi; 2000 Sep; 38(9):676-81. PubMed ID: 11109804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of FDG-PET in the assessment of survival prognosis in melanoma.
    Pleiss C; Risse JH; Biersack HJ; Bender H
    Cancer Biother Radiopharm; 2007 Dec; 22(6):740-7. PubMed ID: 18158764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET.
    Jones DN; McCowage GB; Sostman HD; Brizel DM; Layfield L; Charles HC; Dewhirst MW; Prescott DM; Friedman HS; Harrelson JM; Scully SP; Coleman RE
    J Nucl Med; 1996 Sep; 37(9):1438-44. PubMed ID: 8790188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid normalization of osseous FDG uptake following traumatic or surgical fractures.
    Zhuang H; Sam JW; Chacko TK; Duarte PS; Hickeson M; Feng Q; Nakhoda KZ; Guan L; Reich P; Altimari SM; Alavi A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1096-103. PubMed ID: 12761597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in sarcomas].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S96-102. PubMed ID: 12739341
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group].
    Franzius C; Schulte M; Hillmann A; Winkelmann W; Jürgens H; Bockisch A; Schober O
    Chirurg; 2001 Sep; 72(9):1071-7. PubMed ID: 11594280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of therapy response by FDG PET in pediatric patients.
    Franzius C; Schober O
    Q J Nucl Med; 2003 Mar; 47(1):41-5. PubMed ID: 12714953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coincidence FDG-PET in the evaluation of Langerhans' cell histiocytosis: preliminary findings.
    Binkovitz LA; Olshefski RS; Adler BH
    Pediatr Radiol; 2003 Sep; 33(9):598-602. PubMed ID: 12879314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a role for FDG PET in the diagnosis of musculoskeletal neoplasms?
    Messa C; Landoni C; Pozzato C; Fazio F
    J Nucl Med; 2000 Oct; 41(10):1702-3. PubMed ID: 11038001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.